- Rituximab: Uses, Dosage, Side Effects Warnings - Drugs. com
Rituximab is given by IV infusion (an infusion into a vein) by a healthcare provider Rituximab is not chemotherapy, it is a type of immunotherapy called a targeted cancer treatment
- Rituximab - Wikipedia
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells [22] When it binds to this protein it triggers cell death
- RITUXAN® (rituximab) Medication for RA, NHL, CLL, GPA, MPA PV
Find info for patients about RITUXAN® (rituximab) medication for RA, NHL, CLL, GPA, MPA, and PV See full safety and Boxed Warning for more information
- Rituximab - Cancer Research UK
Rituximab is a type of targeted cancer drug called a monoclonal antibody Find out about how you have it, possible side effects and other important information
- Rituximab: Uses Side Effects - Cleveland Clinic
Rituximab is a synthetic antibody (protein) that can target antigens, or substances that can cause an immune response This medication treats non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis and pemphigus vulgaris
- Rituxan, Truxima (rituximab) dosing, indications, interactions, adverse . . .
Medscape - Dosing for Rituxan, Truxima (rituximab), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy lactation schedules, and cost information
- Rituximab (intravenous route) - Side effects uses - Mayo Clinic
Rituximab injection is used alone or together with other medicines to treat a type of cancer called non-Hodgkin's lymphoma (NHL) It is also used in combination with other cancer medicines to treat mature B-cell non-Hodgkin's lymphoma (NHL) and mature B-cell acute leukemia (B-AL)
- Rituximab: Principles of use and adverse effects in . . . - UpToDate
The mechanism of action, administration, dosing, and adverse effects of rituximab are presented here The relative role and efficacy of rituximab for the treatment of specific rheumatic diseases are described in detail separately:
|